Rx · PZN 18808613
AMOXICLAV Aurobindo 250 mg/62,5 mg powder suspension Hst.USA
German trade nameAMOXICLAV Aurobindo 250 mg-62,5 mg Pulver Suspension Herstellung USA
According to the data available to us: no longer marketed
No observed availability
0.0out of 10
Storage temperature and transport temperature
Highest known
purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
This figure is a rounded approximation. We are happy to advise you on your terms for AMOXICLAV Aurobindo 250 mg/62,5 mg powder suspension Hst.USA.
Review purchasing termsAMOXICLAV Aurobindo 250 mg/62,5 mg powder suspension Hst.USA contains the active ingredient Amoxicillin and beta-lactamase inhibitor (German Amoxicillin und Beta-Lactamase-Inhibitoren). One pack size is recorded (PZN 18808613). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.
According to the data available to us, AMOXICLAV Aurobindo 250 mg/62,5 mg powder suspension Hst.USA is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.
Request a source of supply